Playback speed
10 seconds
Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer
By
Lilly Medical Affairs
FEATURING
Joyce O’Shaughnessy
By
Lilly Medical Affairs
FEATURING
Joyce O’Shaughnessy
211 views
October 23, 2024
In this video, renowned oncologist Dr. Joyce O’Shaugnessy offers valuable insights into best practices for caring for and effectively communicating with patients diagnosed with high-risk HR+, HER2- early breast cancer.
To access additional videos and download free resources click here.
VV-OTHR-US-DEL-3291 © 2024 Lilly USA, LLC. All Rights Reserved.
Comments are disabled for this content.